SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Role of thiopurines as disease-modifying agents in Crohn's disease.

Blackwell, J; Saxena, S; Pollok, RC (2018) Role of thiopurines as disease-modifying agents in Crohn's disease. Gut, 67 (12). pp. 2229-2230. ISSN 1468-3288 https://doi.org/10.1136/gutjnl-2017-315840
SGUL Authors: Pollok, Richard Charles G

[img] Microsoft Word (.docx) Accepted Version
Available under License ["licenses_description_publisher" not defined].

Download (16kB)
Item Type: Article
Additional Information: This article has been accepted for publication in Gut following peer review. The definitive copyedited, typeset version Blackwell J, Saxena S, Pollok RC Role of thiopurines as disease-modifying agents in Crohn’s disease Gut 2018;67:2229-2230 is available online at: http://dx.doi.org/10.1136/gutjnl-2017-315840
Keywords: 6-mercaptopurine, antibody targeted therapy, azathioprine, crohn’s disease, ibd surgery, 6-mercaptopurine, antibody targeted therapy, azathioprine, crohn’s disease, ibd surgery, Gastroenterology & Hepatology, 1103 Clinical Sciences, 1114 Paediatrics And Reproductive Medicine
SGUL Research Institute / Research Centre: Academic Structure > Infection and Immunity Research Institute (INII)
Journal or Publication Title: Gut
ISSN: 1468-3288
Language: eng
Dates:
DateEvent
December 2018Published
3 January 2018Published Online
15 December 2017Accepted
Publisher License: Publisher's own licence
PubMed ID: 29298871
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/110007
Publisher's version: https://doi.org/10.1136/gutjnl-2017-315840

Actions (login required)

Edit Item Edit Item